SCHEMBL30126314

SCHEMBL30126314

C=CC(=O)N1CC[C@H](c2ccc3ncnc(Nc4cccc(Cl)c4F)c3c2)C1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.64
ERBB2 P04626 5/20 0.60
RET P07949 2/20 0.53
ABL1 P00519 1/20 0.53
RAF1 P04049 1/20 0.53
LCK P06239 1/20 0.53
SRC P12931 1/20 0.53
FGFR2 P21802 1/20 0.53
FLT4 P35916 1/20 0.53
KDR P35968 1/20 0.53
TEK Q02763 1/20 0.53
RIPK2 O43353 1/20 0.52
MET P08581 1/20 0.52
EPHB2 P29323 1/20 0.52
TEC P42680 1/20 0.52
EPHB4 P54760 1/20 0.52
EPHA4 P54764 1/20 0.52
BTK Q06187 1/20 0.52
KCNH2 Q12809 1/20 0.52
TNK1 Q13470 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30126688 1.00 EGFR (0.64) EGFRERBB2RETABL1RAF1
SCHEMBL30126818 0.96 EGFR (0.61) EGFRERBB2RETABL1RAF1
SCHEMBL30126249 0.96 EGFR (0.61) EGFRERBB2RETABL1RAF1
SCHEMBL30126337 0.93 EGFR (0.66) EGFRERBB2RETABL1RAF1
SCHEMBL30127497 0.90 EGFR (0.66) EGFRERBB2RETRIPK2MET
SCHEMBL30127577 0.90 EGFR (0.66) EGFRERBB2RETRIPK2MET
SCHEMBL30127603 0.90 EGFR (0.66) EGFRERBB2RETRIPK2MET
SCHEMBL30126997 0.90 EGFR (0.53) EGFRERBB2RETRIPK2MET
SCHEMBL30127549 0.90 EGFR (0.53) EGFRERBB2RETRIPK2MET
SCHEMBL30126275 0.88 EGFR (0.65) EGFRERBB2RETABL1RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022266458-A1 6-HETEROCYCLOALKYL-QUINAZOLINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-12-22 WO disclosed